• 1
    Mancia G, De Backer G, Dominiczak A, et al. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol. 2007;60:968.
  • 2
    Muntner P, Judd SE, Krousel-Wood M, et al. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2010;56:447457.
  • 3
    Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:15981605.
  • 4
    World Health Oragnization. Adherence to Long-Term Therapies. Evidences for Action. Switzerland: World Health Organization; 2003.
  • 5
    Godet-Thobie H, Vernay M, Noukpoape A, et al. [Niveau tensionnel moyen et prévalence de l’hypertension artérielle chez les adultes de 18 a̧ 74 ans, ENNS 2006-207]. Bulletin Epidémiologique Hebdomadaire. 2008;49–50:478482.
  • 6
    Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.
  • 7
    Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:10741090; discussion 1073.
  • 8
    Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51:9094.
  • 9
    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348354.
  • 10
    Al-Qazaz HK, Hassali MA, Shafie AA, et al. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90:216221.
  • 11
    Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother. 2009;43:950957.
  • 12
    Södergård B, Halvarsson M, Tully MP, et al. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther. 2006;31:605616.
  • 13
    Norman SA, Marconi KM, Schezel GW, et al. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med. 1985;1:1017.
  • 14
    Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:14171432.
  • 15
    Costello AB, Osborne JW. Best Practices in Exploratory Factor Analysis: Four Recommendations for Getting the Most from Your Analysis. Practical Assessment, Research & Evaluation; 2005. Available at:, Accessed November 14, 2011.
  • 16
    Koning AJ, Franses PH. Confidence Intervals for Cronbach’s Coefficient Alpha Values. ERIM Report Series Reference; 2003.
  • 17
    Nunnally JC, Bernstein IH. Psychometric Theory, 3rd edn. New York, NY: McGraw-Hill; 2003.
  • 18
    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420428.
  • 19
    Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23:12611266.
  • 20
    Ren XS, Kazis LE, Lee A, et al. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther. 2002;27:4756.
  • 21
    Richardson MA, Simons-Morton B, Annegers JF. Effect of perceived barriers on compliance with antihypertensive medication. Health Educ Q. 1993;20:489503.
  • 22
    National High Blood Pressure Program Education. The Seventh Report of the Joint National Comitte on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. US Department of Health and Human Services; 2003.